SickKids is providing the C-GUIDE™ tool evaluation of iHope's genomic testing for the diagnosis, care, and well-being ...

THOUSAND OAKS, Calif.--(BUSINESS WIRE)--Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to ...

New clinical sites to support engagement with leading orthopedic surgeons and centers of excellence in key European markets, ...

Amwell, a digital care company that connects providers, payers and patients, announced that Hello Heart, a company focused on cardiac health management, has become a partner in its clinical programs ...

Novel KIF18A inhibitor, ATX-295, shows enriched activity in ovarian and TNBC preclinical models with whole genome doubling First-in-class DHX9 inhibitor, ATX-559, demonstrates potent activity in ...

McKesson Pharmacy Systems & Automation has released its McKesson Clinical Programs Solution, a new platform designed to allow pharmacists the ability to create customized wellness programs. The ...

As many smaller providers have exited the market in recent years, some of the nation’s largest nursing homes chains have benefited by picking up buildings and beds that give them entry  into critical ...

Extensive peer-reviewed research has identified biologically active nutrients and biochemical intermediates that play ...

Real-time visibility into recipient engagement for clinical trial operations, sales incentive, HR programs and ...

Are you interested in exploring an opportunity for an elective or observership in the UAB Department of Neurology? Previous observers have continued their training in graduate, medical, postgraduate ...

Clinical ladder programs have great potential for reducing turnover and increasing engagement, says this CNE. The impact of nurse turnover is no secret to CNOs. When health systems lose nurses, it has ...

The study was unlikely to meet its primary endpoint based on overall efficacy and safety results from a pre-planned futility analysis. BeiGene has made the decision to end the clinical development ...